GenAI driven healthcare Insurance fraud and risk management company Consint.AI has raised Rs 5 Cr in a seed round led by Equanimity Ventures and Seafund. The capital raised will be deployed to scale operations through expanded sales outreach and accelerate the development of Generative AI Feature Suite for Health AI Platform. This includes enhancing fraud detection, optimizing claims processing, and delivering personalized clinical care to drive innovation in healthcare. Funding raised in the current round will also support team expansion, infrastructure upgrades, and R&D efforts to strengthen its position as a leader in the health tech solutions market.
Commenting on the investment, Manoj Agarwal, Managing Partner, Seafund, says, “Our focus on emerging tech like GenAI, deep tech, IoT and sustainability has been the guiding force when it comes to backing unique and innovative startups. Consent.AI’s laser sharp focus on solving the problem of healthcare Insurance claims processing and fraud detection improving performance of Insurance and Healthcare institutions is a multi-billion dollar problem to solve and we believe that we have the necessary expertise and network to help the company grow and reach its ambitions.”
Founded in 2020 by Ashish Chaturvedi and later joined by Swadeep Singh as Co-Founder, Consint.AI is a pioneering Generative AI-driven healthcare fraud and risk management company dedicated to transforming healthcare transactions and personalized care. Consint aims to optimize healthcare claims transactions, making it affordable and efficient with its cutting-edge platforms like Risk.ai, engineered to optimize insurance transactions and mitigate fraud, and CIPHR.ai which is designed to enhance critical patient management and streamline claims generation. By harnessing advanced Generative AI solutions, the company empowers businesses across emerging markets and the U.S. to drive value-based care, operational efficiency, and sustainable growth.
In the last 12 months, Consint.AI has achieved remarkable traction, expanding into India, the Middle East, and Africa. The company has recently launched CIPHR.ai, an AI-driven platform tailored for hospitals, built upon custom Generative AI models to revolutionize care personalization in critical patient management. CIPHR.ai provides intelligence at point of care and generates claims transactions enhancing efficiency for healthcare providers. Targeted at emerging health markets and the U.S. Accountable Care Organization (ACO) sector, this platform leverages Generative AI to address the evolving needs of modern healthcare systems
In the last two quarters, the company has achieved significant growth, securing INR 10+ crore in signed contracts. This includes multiple multi-year agreements with leading insurance providers and hospital systems, highlighting strong market validation and growing demand for its innovative solutions, particularly in the areas of Generative AI and Document Forensics. These strategic partnerships underscore the company's commitment to delivering innovative solutions and solidifying its presence in emerging markets.
Ashish Chaturvedi, Founder and CEO, Consint, says, "This current market traction and milestones highlight the transformative potential of Generative AI in reshaping healthcare as we know it. At Consint, we are pioneering GenAI-driven platforms like CIPHR.ai and Risk.ai to solve complex challenges in healthcare transactions and personalized care. Our focus remains on advancing our Generative AI capabilities to drive innovation, deliver impactful solutions, and empower businesses globally to achieve seamless operations and value-based care. This funding accelerates our mission to lead the charge in AI-powered healthcare transformation."
Consint plans to continue expanding Risk.ai to drive seamless transactions in the emerging InsurTech markets, with a focus on product enhancements and accelerated sales efforts. Additionally, it aims to strategically penetrate the U.S. market by establishing a strong product-market fit for its CIPHR.ai Provider Platform, leveraging its Generative AI solutions to meet the specific needs of healthcare providers and Accountable Care Organizations (ACOs). These initiatives are geared towards solidifying the company’s presence in key markets and driving sustainable growth.
Consint.AI is focused on transforming the $600 billion healthcare transaction market by making claims transactions seamless and enabling value-based care. With a projected 4x YoY business growth, the company is strategically expanding its Risk.ai product across private and public insurance markets in the APAC and MEA regions.
_20250107121919_original_image_45.webp)
_20241203131206_original_image_4.webp)
